Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Parasite Immunology|March 1, 1997
Plasmodium falciparum malaria blood stage parasites preferentially inhibit macrophages with high phagocytic activityW W Leitner, U KrzychCurrent Pharmaceutical Design|September 20, 2001
Nucleic acid for the treatment of cancer: genetic vaccines and DNA adjuvantsW W Leitner, P Hammerl, J ThalhamerVaccine|December 2, 1999
DNA and RNA-based vaccines: principles, progress and prospectsW W Leitner, H Ying, N P RestifoGene Therapy|February 16, 2000
The promise of nucleic acid vaccinesN P Restifo, H Ying, L Hwang, et al.Cancer Research|January 26, 2000
Enhancement of tumor-specific immune response with plasmid DNA replicon vectorsW W Leitner, H Ying, D A Driver, et al.Cancer Research|November 24, 2001
Mining the melanosome for tumor vaccine targets: P.polypeptide is a novel tumor-associated antigenC E Touloukian, W W Leitner, P F Robbins, et al.Allergy|June 24, 2006
Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccinesS Scheiblhofer, M Gabler, W W Leitner, et al.Gene Therapy|December 5, 2008
Role of TLR3 in the immunogenicity of replicon plasmid-based vaccinesS S Diebold, O Schulz, L Alexopoulou, et al.Infection and Immunity|September 19, 2000
Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite proteinR Weiss, W W Leitner, S Scheiblhofer, et al.European Journal of Immunology|March 10, 2001
Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infectionS Scheiblhofer, D Chen, R Weiss, et al.Pageof 2